Stock market plunge should incentivize firms to develop a coronavirus cure
- March 12, 2020
- UCI economics professor Linda Cohen and Amihai Glazer explain via The Hill
The $8 billion emergency spending bill to deal with coronavirus includes $3 billion that can be used for the research and development of a coronavirus vaccine or treatment. There’s a better way: The U.S. government should take advantage of the recent stock market plunge to incentivize firms to develop a coronavirus cure, vaccine, or other approaches.
We call this proposal the Epidemic Market Solution or EMS. The government should offer each of 10 firms stock options worth ten billion dollars if the Dow Jones increases by 15 percent over the next six months, and maintains that average increase over a month.
A coronavirus cure or vaccine would generate such an increase. For example, if a firm has $10 billion in options based on index funds, and a new cure or progress towards a cure causes the stock market to rise by 15 percent, the firm would make a profit of $1.5 billion. An even better response might be an increase in the market by 20 percent; in this case, the firm would make a profit of $2 billion.
Read on, courtesy of The Hill: https://thehill.com/opinion/finance/487335-stock-market-plunge-should-incentivize-firms-to-develop-a-coronavirus-cure.
Related News Items
- Experts look at Angel Stadium deal before Anaheim council's big vote Friday
- What tech boom? UCI professor muted on OC
- Everything you think you know about corporate tax incentives is wrong
- Why corporate tax incentives don't get results
- Why cities should stop playing Amazon's game and quit offering companies tax incentives